Investor Presentaiton
Rest of the World
Company Presence
■ ROW includes markets of South
East Asia, MENA, Russian
Federation & Africa
☐
■ Presence in emerging markets such as South East Asia,
MENA, LATAM, CIS and Africa
■ In these countries, specific countries like Iraq, Ukraine
and South East Asia are targeted
■ In process of launching new products and obtaining
product registration for over 100 products in emerging
markets.
Overview of the market
Spending in emerging markets is
expected to grow at ~5% CAGR to
reach USD 475 billion by 2024*
Rest of the World
(9MFY22)
46.5
(Cr.)
©2021 - Marksans Pharma Limited, All Rights Reserved.
(5.0)%
Total Revenue
Y-o-Y Growth
4.3%
Contribution
to Total Revenues
*Source: Internal Estimates
30View entire presentation